Overall, consumer health is expected to perform well, due to increased demand as a result of COVID-19, with most areas product areas expected to register double-digit current value growth. Though 2020 current value growth is not expected to be as high as in 2019, a lot of the growth over the review period was driven by inflation rather than...
In response to COVID-19 the Swiss government introduced a range of measures to limit the spread of the virus, with this having a mixed impact on the various categories of consumer health. Nonetheless, there was an overall improvement seen in 2020, spurred on by stronger sales in key categories including analgesics, cough, cold and allergy...
Dermatologicals is set to record higher growth compared to 2019, with 2% growth predicted against 1% recorded the previous year. Sales are expected to be slightly boosted by the side effects of consumers wearing protective equipment and face masks - used to prevent the spread of COVID-19. This includes cases of eczema flaring up due to long...
Consumer health value sales will continue to grow in 2020, despite the negative economic impact of COVID-19 on the economy. Lower purchasing power among middle-income consumers and the rising cost of healthcare in Argentina have fuelled a shift towards self-medication in recent years, thus encouraging preventive healthcare. Following this...
Consumer health is expected to see higher current value growth in 2020 than was seen the previous year. One of the factors driving growth in this year is COVID-19. As news about the virus emerged and the country went into lockdown, consumers began panic-buying in March, stockpiling certain consumer health products, such as analgesics, cough,...
In line with the steady growth recorded during the review period, current value sales of dermatologicals are set to continue to increase in 2020. Thus far, there has been little direct impact on demand for dermatologicals as a result of the COVID-19 pandemic, other than the increase in awareness of maintaining high levels of cleanliness and...
Consumer health has seen slightly higher growth overall in current value terms in 2020 compared to the previous year. Nevertheless, growth has remained largely in line with the review period average, with economic pressures preventing any more significant gains. When COVID-19 first appeared in South Africa there was some initial stockpiling...
Current value growth of dermatologicals in 2020 is being driven by rising unit prices, which, alongside compensated inflation growth, are increasing as a result of the reducing share of cheap generics as consumers increasingly prioritise efficiency over price. Dermatologicals in Ukraine report offers a comprehensive guide to the size...
After seeing consistent growth over the review period, dermatologicals is anticipated to see noticeable current value growth in 2020 overall. Cameroon was placed under a partial lockdown in March, which led some consumers to panic and stockpile in order to avoid running out of products in the future. It is likely that some consumers stockpiled...
China’s demand for OTC Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...